Dr. Laura Kathleen Hummers, MD

Dr. Hummers practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Hummers' NPI, 1104879527, was assigned on May 18, 2006. Dr. Hummers graduated from University of Rochester Medical Center in 1997. Dr. Hummers holds Maryland license D58772.

Dr. Hummers' primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Hummers' primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Hummers is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Hummers to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hummers practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Hummers' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Hummers is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Hummers' licenses on file in 5 states: Maryland, Florida, North Carolina, Alabama and Pennsylvania.

Dmand AI lists arthritis, gout, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Hummers treats.

CMS data shows 352 Medicare services from Dr. Hummers across 5 procedure codes in 2024, for 157 Medicare patients. Medicare paid $24,205 for them. Every service was in an office.

CMS counts 157 Medicare patients who saw Dr. Hummers in 2024. The largest group is 65 to 74, with 83 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hummers' median patient age at 63, with 77% women.

In 2024, Dr. Hummers wrote 901 Medicare Part D claims for 111 patients. 86% of them were for generic drugs. CMS names the drug for 698 of them, across 23 drugs with 11 or more claims each, at $1,515,578 in total drug cost. In 2023, CMS named 571 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hummers for performance year 2024, reported as part of a group. CMS lists Dr. Hummers as offering telehealth.

Dmand AI links 155 papers to Dr. Hummers, published from 2006 to 2025. 2018 was the busiest year, with 9. The most frequent topics are Scleroderma, Systemic, Hypertension, Pulmonary and Lung Diseases, Interstitial. Dr. Hummers has published most often in Arthritis Care Res (Hoboken). Dr. Hummers' most frequent co-authors are Fredrick M. Wigley, MD, Maureen D. Mayes, MD and Tracy Minan Frech, MD.

Dmand AI links Dr. Hummers to 13 clinical trials, 5 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Scleroderma, Systemic, Scleroderma, Diffuse and Connective Tissue Diseases. Corbus Pharmaceuticals Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Hummers that name 2 trials.

CMS Open Payments shows 94 general payments to Dr. Hummers from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $28,684. It also lists 16 research payments totaling $5,562 from 2017 to 2021, naming 2 clinical trials.

Dmand AI lists 2 awards for Dr. Hummers, most recently CMS Stage 1 EHR in 2014.

Dr. Hummers graduated from University of Rochester Medical Center in 1997. Dr. Hummers is a member of ACR.

Dr. Hummers is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.